Top Industry Leaders in the Diverticular Disease Market
Latest Diverticular Disease Companies Updates:
BioMarin and Ovid Therapeutics Both companies received orphan drug designation from the FDA for their respective drugs, Kyndrisa (naloxone hydrochloride) and Nuplazid (pibosertib), for the treatment of diverticulitis, a severe form of diverticular disease.
Neurocrine Biosciences This company is developing a nasal spray called NT802 for the treatment of diverticulitis. The drug is currently in Phase 2 clinical trials.
Emergent Medical Solutions This company offers a rapid diagnostic test for diverticulitis called the Serotonin Syndrome Evaluation Rapid Assessment Kit (SSERAK).
List of Diverticular Disease Key companies in the market:
- Sucampo Pharmaceuticals, Inc
- Abbott Laboratories
- Ardelyx, Inc
- Synergy Pharmaceuticals
- Novartis AG
- Astellas Pharma Inc
- Valeant Pharmaceuticals International Inc